King Pharmaceuticals KG
-
Pain Therapeutics ([[PTIE]] +19%) and Durect ([[DRRX]] +25.5%) both soar on the back of positive comments out of Pfizer's (PFE) conference call about Remoxy, an oxycodone capsule the pair have been ...
… an oxycodone capsule the pair have been developing. PTIE sub-licensed Remoxy's commercialization rights to King Pharmaceuticals , which is a subsidiary of PFE , and the pharma-giant noted in its call that it's had a productive meeting …
-
New Morningstar Analyst Report for Zoetis Inc.
… the acquisitions of Fort Dodge (Wyeth) and Alpharma ( King Pharma ) and from Pfizer's companywide cost-reduction program ..... health-care firm, such as Pfizer's acquisition of King Pharma (Alpharma). The only data point worth noting is the …
-
PJP PowerShares Dynamic Pharmaceuticals ETF Analysis, Report, Research, 5 Star Rating – Morningstar
… TEVA acquisition of German generic drugmaker Ratiopharm Group International, Sanofi's SNY acquisition of Genzyme, Merck of Germany's takeover of Millipore, and Pfizer's PFE acquisition of pain drugmaker King Pharmaceuticals .
-
All You Need To Know About Remoxy
… has a strategic alliance with drug manufacturing giant Pfizer ( PFE ) (as a result of Pfizer's acquisition of King Pharmaceuticals in March of 2011) to market and distribute all of the drugs in their pipeline. The third company involved with …
-
IHE iShares Dow Jones US Pharmaceuticals ETF Analysis, Report, Research, 5 Star Rating – Morningstar
… TEVA acquisition of German generic drugmaker Ratiopharm Group International, Sanofi's SNY acquisition of Genzyme, Merck of Germany's takeover of Millipore, and Pfizer's PFE acquisition of pain drugmaker King Pharmaceuticals .
-
XPH SPDR S&P Pharmaceuticals ETF Analysis, Report, Research, 5 Star Rating – Morningstar
… TEVA acquisition of German generic drugmaker Ratiopharm Group International, Sanofi's SNY acquisition of Genzyme, Merck of Germany's takeover of Millipore, and Pfizer's PFE acquisition of pain drugmaker King Pharmaceuticals .
-
Pain Therapeutics - Another Oxycodone Remix
… different additives or made available through new delivery methods. Pain Therapeutics ( PTIE ) is partnered with King Pharmaceuticals , a subsidiary of Pfizer ( PFE ), in hopes of commercializing an oxycodone-based treatment called Remoxy …
-
RXL ProShares Ultra Health Care ETF Analysis, Report, Research, 5 Star Rating – Morningstar
… acquisition of Genzyme, Merck of Germany's takeover of Millipore, and Pfizer's PFE acquisition of pain-drug maker King Pharmaceuticals . In our view, an ETF can help health-care investors diversify away company-specific risks. Granted, all …
-
Merck's Next-Gen Sleep Disorder Drug - A Blockbuster?
… market, Zolpidem ( Ambien and Ambien CR ) was marketed by Sanofi-Aventix ( SNY ). Zaleplon ( Sonata ) is made by King Pharmaceuticals and Eszopiclone ( Lunesta ) is made by Sunovion. The drugs are chemically distinct from benzodiazepines, but …
-
PPH Market Vectors Pharmaceutical ETF ETF Analysis, Report, Research, 5 Star Rating – Morningstar
… acquisition of Genzyme, Merck of Germany's takeover of Millipore, and Pfizer's PFE acquisition of pain-drug maker King Pharmaceuticals . In our view, an ETF makes a lot of sense for health-care investors. No matter how deep your knowledge of …